Patent · US Active

Chemical compounds

US8853416B2 · kind B2 · utility

2Cited by
8References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 12, 2013
Grant dateOct 7, 2014
Priority date
Expiry dateJun 12, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are compounds of Formula III. Also disclosed are salts of the compounds, pharmaceutical composition comprising the compounds or salts, and methods for treating HCV infection by administration of the compounds or salts.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.